CTIS2022-501717-31-00进行中（未招募）1 期
Effect of intravenous immunoglobulins on painful sensory neuropathy evaluated by aggregated N-of-one trials
Sorlandet Sykehus HF0 个研究点目标入组 30 人开始时间: 2022年8月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •18-65 years, Painful sensory neuropathy fulfilling diagnostic criteria for idiopathic small fiber neuropathy or idiopathic sensory neuronopathy, Pain intensity at least 5.0 on Numeric Rating Scale (NRS) lasting at least 4 weeks, Signed written informed consent
排除标准
- •Change of pain medication in the 30 days prior to inclusion, Treatment with IVIG or other immunomodulatory agents the last 4 weeks, Contraindications to IVIG ie previous stroke, myocardial infarction, or other thrombotic events, hypertension (uncorrected), smoking, diabetes, prolonged immobilization, hypercoagulable state, IgA deficiency, renal failure, ongoing heart disease, hypovolemia, previous allergic reactions to IVIG, Females who are breastfeeding, pregnant, or unwilling to practice adequate contraception throughout the study
研究者
相似试验
尚未招募
4 期
IVIG in Painful Sensory NeuropathySensory NeuropathySmall Fiber NeuropathyNCT06183008Sorlandet Hospital HF20
进行中（未招募）
不适用
Etude des effets des immunoglobulines intraveineuses sur l'excitabilité nerveuse dans les neuropathies démyélinisantes dysimmunes chroniques - IVIGPatients suivis dans le service de Neurologie de l'Hôpital Henri Mondor pour une neuropathie démyélisante dysimmunes chroniques.Patients nécessitant un traitement par immunoglobulines intraveineuses et suivis dans le service de Médecine Interne de l'Hôpital Henri MondorMedDRA version: 8.1Level: PTClassification code 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathyEUCTR2006-006392-21-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)70
已完成
不适用
Comparison of the effect of Intravenous immunoglobulin and rhophylacIdiopathic thrombocytopenic purpura.Idiopathic thrombocytopenic purpura (Evans syndrome)IRCT2012102811289N1Arak University of Medical Sciences, Vice Chancellor for Research60
招募中
不适用
A research in patients with progressive multiple sclerosis, primary as well as the secondary form. Two groups of patients in which one group of patients receives IVIG medication and the patients of the other group do not receive medication for their progressive multiple sclerosis. With questionnaires we measure if there is a difference in quality of life and fatigue in these two groups of patients.NL-OMON27216Self financed study.100
已完成
不适用
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemiaJPRN-UMIN000015179agoya University Graduate School of Medicine30